Plasmodium Immunotherapy for Advanced Malignant Solid Tumors
Plasmodium Immunotherapy for Advanced Malignant Solid Tumors
Recruiting · NCT04165590 · Registry updated 2024-02-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Plasmodium Immunotherapy for Advanced Malignant Solid Tumors | Advanced Malignant Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2024-02-20 | NCT04165590 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CAS Lamvac Biotech Co., Ltd. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Yunnan Kungang Hospital | Kunming | China | 1 |